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Abstract
Introduction:  Bismuth  subgallate  is  a  salt  derived  from  heavy  metal.  The  aim  of  this  study  was
to evaluate  the  effect  of  this  salt  on  some  phases  of  healing.
Objectives:  To  assess  the  effect  of  subgallate  on  mucosa  and  to  evaluate  the  association
between  the  use  of  bismuth  subgallate  and  neogenesis  of  vessels  in  oral  mucosal  wounds.
Methods:  This  was  a  prospective  and  experimental  study.  This  study  used  sixty  rats,  which  were
divided into  control  and  experimental  groups.  The  animals  were  submitted  to  a  surgical  proce-
dure, which  caused  oral  mucosal  injury.  A  saline  solution  was  applied  on  the  wound  of  the  control
group, and  in  the  experimental  group,  a  solution  of  bismuth  subgallate  was  administrated.
Results:  The  experimental  group  showed  greater  inﬂammatory  reaction  with  increasing
monomorphic  proliferation.  There  was  increased  vessel  proliferation  in  the  control  group.
Conclusion:  Bismuth  subgallate  had  a  negative  inﬂuence  on  the  healing  process,  delaying  the
rate of  new  vessel  formation  and  optimal  wound  healing.
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PALAVRAS-CHAVE
Cicatrizac¸ão;
Tonsilectomia;
Indutores  da
angiogênese
Estudo  experimental  sobre  os  efeitos  do  subgalato  de  bismuto  no  processo
inﬂamatório  e  de  angiogênese  em  mucosa  bucal
Resumo
Introduc¸ão:  O  subgalato  de  bismuto  é  um  sal  derivado  de  metal  pesado.  A  ideia  desta  pesquisa
é avaliar  sua  interferência  em  alguma  das  fases  da  cicatrizac¸ão.
Objetivo:  Delinear  a  ac¸ão  do  subgalato  em  mucosas.  Avaliar  a  relac¸ão  entre  a  utilizac¸ão  do
subgalato  de  bismuto  e  a  neoformac¸ão  de  vasos  nas  feridas  em  mucosa  oral,  para  evidenciar  o
possível benefício  resultante  do  seu  uso.
Método:  Estudo  experimental,  prospectivo.  Utilizou-se  sessenta  ratos,  que  foram  divididos
igualmente  em  grupo  controle  e  experimento.  Foram  submetidos  a  um  procedimento  cirúr-
gico onde  foi  feito  uma  lesão  na  mucosa  oral  dos  animais,  após,  uma  soluc¸ão  de  soro  ﬁsiológico
foi aplicada  sobre  a  lesão  do  grupo  controle  e  sobre  a  ferida  do  grupo  experimento  foi  aplicada
uma soluc¸ão  de  subgalato  de  bismuto.
Resultados:  o  grupo  experimento  apresentou  maior  reac¸ão  inﬂamatória  com  crescente
proliferac¸ão monomórﬁca.  Vasos:  houve  maior  proliferac¸ão  no  grupo  controle.
Conclusões:  concluiu-se  que  o  subgalato  de  bismuto  teve  uma  ac¸ão  negativa  no  processo  de
cicatrizac¸ão, atrasando  a  velocidade  de  formac¸ão  dos  neovasos  e  a  cicatrizac¸ão  ideal  da  ferida
operatória.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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ismuth  subgallate  or  bismuth  oxygallate  is  a  yellowish  sub-
tance,  which  presents  as  an  odorless  powder  that  suffers
iscoloration  in  the  presence  of  sunlight.1 It  is  a  heavy
etal  salt  that  is  poorly  absorbed,  and  has  strong  astringent
ower.2
Dermatol,  another  name  for  the  salt,  has  been  increas-
ngly  used  by  professionals  from  the  otorhinolaryngology  and
entistry  areas.  Due  to  its  hemostatic  and  astringent  proper-
ies,  the  substance  may  be  used  in  many  ways;  among  them,
s  topical  treatment  for  open  wounds,  treatment  of  gastro-
uodenal  ulcers,  diarrhea,  odor  control  in  colostomies,  in
ental  surgeries,  epistaxis  management  and,  empirically,
n  adenotonsillectomies.
The  literature  is  not  in  uniﬁed  opinion  about  the  ben-
ﬁts  of  subgallate  in  hemostasis  or  the  healing  effect  and
here  are  discrepancies  among  studies.  It  does  not  address
hether  there  are  beneﬁcial  effects  on  healing,  and  there
re  few  studies  with  comparison  or  control  groups.  How-
ver,  Arroyo  Júnior  et  al.2 found  that  bismuth  subgallate
as  an  effect  on  factor  12  activation,  which  accelerates  the
ntrinsic  pathway  in  the  coagulation  cascade,  contributing  to
he  hemostatic  characteristic  of  this  compound.  The  authors
lso  discussed  the  possibility  that  bismuth  subgallate  might
nhibit  ﬁbrinolysis  and,  thereby,  increase  ﬁbrosis.
According  to  Hernández-Paz  et  al.3 (from  the  otolaryn-
ology  service  of  the  outpatient  surgery  center  ISSSTE,  in
exico  City,  Mexico),  some  methods  are  currently  being
nvestigated  to  reduce  or  prevent  intraoperative  or  postop-
rative  bleeding  during  adenotonsillectomy.  For  this  reason,
everal  means  have  been  compared,  such  as  a  laser,  elec-
rodissection,  cold  ablation,  harmonic  scalpel,  or  radio
requency.  However,  none  of  these  techniques  showed  100%
fﬁcacy.  In  this  search  for  an  ideal  method,  two  substances
c
o
cerived  from  bismuth  (subgallate,  and  bismuth  subsalicy-
ate)  have  been  reported,  which  exhibit  hemostatic  effects
hat  activate  factor  XII  via  the  intrinsic  coagulation  pathway.
hen  applied  topically  to  the  wound,  immediately  after  tis-
ue  removal,  bleeding  is  signiﬁcantly  decreased.
Padilla  et  al.4 (from  the  department  of  otorhinolaryn-
ology  of  Centro  Médico  Nacional  La  Raza,  IMSS,  Mexico
ity,  Mexico)  described  bismuth  subgallate  as  a heavy  metal
hat  accelerates  clot  formation  and  improves  hemostasis.
hey  also  reported  that  some  authors  have  suggested  only
drenaline  only  as  the  active  ingredient  that  helps  hemosta-
is,  due  to  its  vasoconstrictor  effect.  According  to  Padilla
t  al.,  there  have  been  few  studies  using  bismuth  subgallate
lone  (without  adrenaline)  to  demonstrate  its  hemostatic
ffect  and,  considering  that,  they  proposed  a  clinical  trial
omparing  the  hemostatic  effect  of  subgallate  in  adenoton-
illectomies,  compared  to  a  control  group  that  used  only
ry  gauze.  In  the  present  study,  bismuth  subgallate  showed
o  activity  as  a  hemostatic  agent  to  reduce  intraoperative
leeding.
The  goal  of  this  study  was  to  assess  whether  bismuth
ubgallate  interferes  in  any  of  the  healing  stages.  As  it
s  an  inexpensive  easy-to-handle  powder,  its  use  could  be
eneﬁcial  from  the  perspective  of  healing,  if  case  studies
ocument  that  beneﬁt.
Many  otorhinolaryngology  services  do  not  use  bismuth
ubgallate,  reporting  that  the  immediate  postoperative
esults  of  its  use  show  no  beneﬁts,  whereas  others  report
hat  it  helps  to  control  bleeding.  The  studies,  in  general,
ocus  on  its  use  in  relation  to  immediate  postoperative
leeding  control.
Wound  healing  occurs  in  several  simultaneous  pro-
esses,  and  it  is  not  possible  to  distinguish  the  beginning
r  the  end  of  each;  however,  for  didactic  purposes,  it
an  be  divided  into  stages:  coagulation,  inﬂammation,
the  inﬂammatory  process  19
Figure  1  Surgical  wound  induction.
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proliferation,  contraction,  and  remodeling.1 The  phase  of
proliferation  is  subdivided  into  re-epithelialization,  ﬁbropla-
sia,  and  angiogenesis.
As angiogenesis  is  an  important  healing  phase,  if  bismuth
subgallate  induces  increased  angiogenic  activity,  early  and
increased  neovascularization  is  expected,  culminating  in  an
optimization  of  the  healing  process.
Angiogenesis  occurs  from  preexisting  vessels,  in  serum,
and  in  the  extracellular  matrix.  These  new  vessels  assist  in
granulation  tissue  formation,  as  well  as  by  supplying  nutri-
ents  and  oxygen  to  tissues,  thus  they  are  crucial  for  the
healing  process,  corresponding  to  60%  of  tissue  repair.5,6
The  formation  of  new  vessels  is  essential  for  tissue  regen-
eration  and,  therefore,  local  factors,  chemical  mediators,
extracellular  matrix,  and  metabolic  gradients  show  concom-
itant  development.7
Among  the  objectives  of  this  study,  the  general  one  was
outlining  subgallate  action  on  mucosal  tissue  and  as  a  spe-
ciﬁc  objective,  the  assessment  of  the  association  between
the  use  of  bismuth  subgallate  and  the  formation  of  new
vessels  in  oral  mucosa  wounds,  thus  showing  the  possible
resulting  beneﬁts  of  its  use,  so  that  new  protocols  can  ﬁnally
be  utilized  in  otorhinolaryngology  services  involving  the  use
of  this  salt,  mainly  in  oral  cavity  surgeries.
Methods
Surgical  procedure
The  experiments  were  carried  out  from  September  24  to
October  1,  2012.  A  total  of  60  young  adult  male  Wistar
rats  (Rattus  norvegiccus  albinus),  aged  110  days  and  mean
weight  between  250  g  and  300  g,  were  assessed.  The  sample
size  was  estimated  according  to  studies  in  the  literature  and
the  project  followed  the  guidelines  of  Law  11,797  of  Octo-
ber  8,  2008,  regulated  by  Decree  No.  6899  of  15  July  2009
and  the  recommendations  of  the  Brazilian  College  of  Animal
Experimentation.  The  study  was  performed  after  approval
by  the  ethics  committee  on  animal  studies  under  No.  666.
The  animals  were  anesthetized  with  0.1  mL/100  g  body
weight  with  a  mixture  of  1  mL  of  ketamine  (50  mg)  and  1  mL
xylazine  2%  (20  mg),  IM,  in  the  posterior  portion  of  the  thigh.
Subsequently,  they  were  placed  in  the  prone  position  and
had  the  lower  and  upper  limbs  attached  to  a  wooden  support
(Fig.  1).  With  the  aid  of  a  suitable  mouth  opener,  a  wound
of  approximately  0.7  cm  in  diameter  was  made  on  the  left
side  of  the  oral  mucosa,  by  using  a  biopsy  forceps.
At  this  point,  it  was  decided  to  create  a  single  wound
to  reduce  the  aggression  to  the  animals  and  to  facilitate
their  recovery;  the  left  side  was  chosen  to  standardize  the
study.  It  was  decided  to  use  the  biopsy  forceps  instead  of
a  punch  biopsy  device  due  to  the  chance  that  the  second
tool  would  completely  pierce  the  rat’s  oral  cavity  wall.  After
the  surgery,  the  animals  received  dipyrone  (at  a  dose  of
10  mg/kg)  IM  for  analgesia,  according  to  what  was  proposed
to  and  accepted  by  CEUA.
The  animals  were  randomly  marked  and  divided  into
three  groups  of  10  animals,  which  received  0.5  mg  of  topic
bismuth  subgallate  after  wound  with  biopsy  forceps.  Each
group  was  reoperated  for  wound  removal  and  evaluation
after  24  h  (GII),  three  days  (GIII),  and  seven  days  (GIV)  after
l
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t
tFigure  2  Wound  removal  on  D7.
he  lesion  (Fig.  2).  The  remaining  30  animals  comprised  the
ontrol  group  (GI),  which  was  also  divided  into  three  groups
f  ten  animals,  which  were  also  evaluated  after  24  h,  three
ays,  and  seven  days  (Table  1).
The  control  group  was  treated  by  washing  the  wound
ith  0.9%  NaCl  solution,  as  recommended  by  the  literature.
he  fragment  was  removed  with  a  margin  of  approximately
.5  cm  around  the  entire  mucosal  lesion,  which  went  as
eep  as  the  buccal  musculature  of  the  rat.  Immediately
fter  the  end  of  each  surgery,  the  animals  were  eutha-
ized  by  a  lethal  intraperitoneal  dose  of  thiopental  sodium
120  mg/kg).  There  was  only  one  loss  during  the  study,  an
nimal  from  the  control  group,  number  57  (Table  2),  ﬁve
ays  post-operatively.
istological  and  immunohistochemical  analysis
he  study  results  were  described  as  mean,  median,  min-
mum,  maximum  values,  and  standard  deviations.  The
onparametric  Mann--Whitney  test  was  used  to  compare  the
tudy  and  control  groups  regarding  the  percentage  of  col-
agen  (mature  and  immature,)  as  well  as  the  cell  count
core  and  the  number  of  vessels.  Comparisons  made  on  the
hree  days  of  assessment  within  each  group  were  made  using
he  nonparametric  Kruskal--Wallis  test.  p-Values  <  0.05  were
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Table  1  Identiﬁcation  of  studied  samples  with  bismuth  subgallate.
Experiment  24  h  Experiment  three  days  Experiment  seven  days
Animal  Weight  (g)  Animal  Weight  (g)  Animal  Weight  (g)
1  272.91  11  261.56  21  287.28
2 278.63  12  256.09  22  262.75
3 252.08  13  259.66  23  281.18
4 250.87  14  267.43  24  261.65
5 266.3  15  283.81  25  274.4
6 255.64 16  254.11  26  262.44
7 275  17  257.74 27  273.47
8 249.6 18  272.17 28  258.95
9 273.37  19  263.36  29  277.13
10 272.34  20  263.58  30  265.94
Table  2  Identiﬁcation  of  studied  samples  from  the  control  group.
Control  24  h Control  three  days Control  seven  days
Animal  Weight  (g)  Animal  Weight  (g)  Animal  Weight  (g)
31  271.06  41  274.35  51  284.02
32 268.96  42  278.96  52  284.6
33 257.99  43  282.05  53  265.88
34 281.5  44  272.44  54  254.1
35 268.2  45  256.63  55  282.46
36 251.8  46  262.35  56  261.76
37 271.26  47  245.71  57  236.3
38 249.7  48  249.17  58  244.34
39 278.79  49  247.94  59  276.49
262.56  60  249.1
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onsidered  statistically  signiﬁcant.  Data  were  analyzed  using
he  SPSS  v.  20.0  software.
The  section  used  for  the  histological  analysis  was  placed
n  identiﬁed  cardboard  and  secured  with  colored  pins  to
chematize  wound  position  in  the  rat.  Subsequently,  it  was
ipped  in  a  container  with  10%  formaldehyde  for  24  h.  After
hat,  it  was  embedded  in  parafﬁn  blocks,  and  sectioned  at
-m  thick  sections.
The  histological  sections  were  stained  with  hematoxylin-
osin  and  picrosirius.  For  each  slide,  the  reading  was
erformed  in  three  ﬁelds  for  both  stains,  with  200× mag-
iﬁcation,  over  the  lesion  area  (Figs.  3  and  4).
With  hematoxylin-eosin  stain,  the  inﬂammatory  process
as  assessed,  counting  monomorphonuclear  and  polymor-
honuclear  cells  and  the  number  of  vessels.  The  picrosirius
tain  assesses  collagen  through  its  speciﬁc  birefringence,
dentifying  the  ﬁber  orientation  through  a  polarizing  optical
icroscope.  The  thicker  ﬁbers,  with  greater  birefringence,
ill  appear  colored  in  orange  and  red  tones,  identifying  the
ype  I  collagen;  the  thinner  ﬁbers,  with  lower  birefringence,
ill  display  a  green  color,  identifying  type  III  collagen.
An  Olympus  BX50  microscope  with  a  3CCD  Pro-S  series
apture  cameras  was  used  together  with  the  Image-Pro  Plus
rogram,  v.  4.5,  by  Cybernetics.  The  images  were  captured
sing  a  Dino-Lite  camera  and  were  analyzed  using  the  appli-
ation  Image  Plus  4.5  for  Windows  in  Pentium  III  computer.
fter  the  reading,  the  areas  with  greater  cellularity  were
i
u
mFigure  3  Mask  used  for  the  reading  of  Picrosirius  staining.
eﬁned,  which  were  submitted  to  a punch,  in  order  to
repare  the  tissue  macroarray  (TMA)  for  immunohistochem-
stry  analysis  (Fig.  5).
After  TMA  was  performed,  the  material  was  sent  for
mmunohistochemical  processing.  The  CD34  marker  was
sed,  which  allowed  the  angiogenesis  process  assess-
ent  by  determining  endothelial  cell  proliferation,  as  its
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Figure  4  Slide  showing  Picrosirius  staining  of  integra.
Figure  6  Mask  used  for  the  reading  of  CD34  marker.
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oFigure  5  Finished  slides  and  parafﬁn  after  punch  was  per-
formed.
antigen  is  a  single-chain  transmembrane  glycoprotein  asso-
ciated  with  human  hematopoietic  progenitor  cells  (Fig.  6).
The  antigen-antibody  reaction  is  deﬁned  by  a  brownish
chemical  reaction,  allowing  the  quantiﬁcation  and  qualiﬁ-
cation  of  the  healing  process  (Fig.  7).
Statistical  analysis
The  analysis  was  performed  taking  into  account  the  study
results,  described  as  mean,  median,  minimum,  maxi-
mum  values,  and  standard  deviations.  The  nonparametric
Mann--Whitney  test  was  used  for  the  comparison  of  the  study
and  control  groups.  Comparisons  of  the  days  of  assessment
within  each  group  were  performed  using  the  nonparametric
Kruskal--Wallis  test.
ResultsCollagen  is  the  main  component  of  tissue  extracellular
matrix.  It  is  structured  into  a  dense  and  dynamic  network,
resulting  from  its  constant  deposition  and  resorption.  Col-
lagen  degradation  starts  early  and  is  very  active  during  the
c
r
m
oFigure  7  Slide  showing  CD34  marker  of  integra.
nﬂammatory  process;  during  this  process,  it  is  possible  to
valuate  the  healing  activity,  mainly  by  investigating  its
mmature  form,  collagen  type  III,  which  comprises  approxi-
ately  40%  of  the  granulation  tissue.
ature  collagen
nitially,  on  each  assessment  day  (one,  three,  and  seven),
he  null  hypothesis  that  the  mature  collagen  percentage  was
qual  in  both  groups  was  tested  vs.  the  alternative  hypothe-
is  of  different  mature  collagen  percentages  (Table  3).  Then,
ithin  each  group,  we  tested  the  null  hypothesis  that  the
ature  collagen  percentage  was  the  same  on  the  three  days
f  assessment  vs.  the  alternative  hypothesis  that  the  per-
entages  were  not  all  the  same.  There  was  no  difference
egarding  the  mature  collagen  percentage  in  the  experi-
ental  group  on  the  assessed  days  (p  =  0.180).  The  same
ccurred  with  the  control  group  (p  =  0.326).
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Table  3  Comparison  in  relation  to  mature  collagen.  The  table  shows  mean,  median,  minimum,  maximum,  and  standard
deviation. It  also  shows  the  p-values  of  statistical  tests.
Day  Group  n  Mean  Median  Minimum  Maximum  SD  p-Valuea
1
Study  10  82.3  86.5  59.6  95.5  12.2
Control 10  88.3  95.0  55.2  99.1  13.9  0.143
3
Study 10  86.2  87.5  63.4  99.2  10.0
Control 10  92.2  92.6  82.0  98.2  5.2  0.123
7
Study 9  91.7  93.7  82.2  97.9  5.2
Control 10  94.7 96.2  80.3  100.0  6.1  0.079
SD, standard deviation.
a Nonparametric Mann--Whitney test, p < 0.05.
Table  4  Comparison  in  relation  to  immature  collagen.  The  table  shows  mean,  median,  minimum,  maximum,  and  standard
deviation. p-Values  of  the  statistical  tests  are  also  given.
Day  Group  n  Mean  Median  Minimum  Maximum  SD  p-Valuea
1
Study  10  17.7  13.5  4.5  40.4  12.2
Control 10  11.7  5.0  0.9  44.8  13.9  0.143
3
Study 10  13.8  12.5  0.8  36.6  10.0
Control 10  7.8  7.4  1.8  18.0  5.2  0.123
7
Study 9  8.3  6.3  2.1  17.8  5.2
Control 10  5.3  3.8  0.0  19.7  6.1  0.079
SD, standard deviation.
a Nonparametric Mann--Whitney test, p < 0.05.
Table  5  Comparison  in  relation  to  inﬂammatory  cell  growth.  The  table  shows  median,  minimum,  and  maximum  values.  p-Values
of statistical  tests  are  also  given.
Day  Group  n  Median  Minimum  Maximum  p-Valuea
1
Study  10  0  −1  0
Control  10  0  −2  0  0.684
3
Study 10  0  −1  2
Control  10  0  −2  1  0.481
7
Study 9  1  0  3
Control  10  0  −1  1  0.043
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inﬂammatory  process  was  equal  in  both  groups  was  tested
vs.  the  alternative  hypothesis  of  different  scores  (Table  5).
Then,  within  each  group,  the  null  hypothesis  that  the
scores  were  the  same  on  the  three  days  of  assessment
was  tested  vs.  the  alternative  hypothesis  that  the  scores
were  not  all  the  same.  For  the  study  group,  the  test
results  indicated  rejection  of  the  null  hypothesis  (p  =  0.016).
Considering  that  a  signiﬁcant  difference  was  found  between
the  days,  they  were  compared  two-by-two  (Table  6).
Table  6  p-Value  assessment.  The  table  shows  p-values  of
statistical  tests.
Compared  days p-Valuea Nonparametric Mann--Whitney test, p < 0.05.
mmature  collagen
nitially,  on  each  assessment  day  (one,  three,  and  seven),
he  null  hypothesis  that  immature  collagen  percentage  was
qual  in  both  groups  was  tested  vs.  the  alternative  hypoth-
sis  of  different  immature  collagen  percentages  (Table  4).
hen,  within  each  group,  the  null  hypothesis  that  imma-
ure  collagen  percentage  was  the  same  on  the  three  days
f  assessment  was  tested  vs.  the  alternative  hypothesis  that
he  percentages  were  not  all  the  same.  The  results  of  imma-
ure  collagen  assessment  showed  no  difference  regarding
ts  their  percentage  on  the  days  assessed  in  the  control
p  = 0.326)  and  experimental  groups  (p  =  0.180).nﬂammatory  process  cell  count
nitially,  on  each  assessment  day  (one,  three,  and  seven),
he  null  hypothesis  that  the  cell  count  score  of  the
Day  one  ×  day  three  0.131
Day one  ×  day  seven  0.003
Day three  ×  day  seven  0.084
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Table  7  Comparison  in  relation  to  the  number  of  vessels.  The  table  shows  median,  minimum,  and  maximum  values.  p-Values
of statistical  tests  are  also  given.
Day  Group  n  Mean  Median  Minimum  Maximum  SD  p-Valuea
1
Study  10  22.3  19.5  7.0  38.0  9.4
Control 10  20.2  19.0  2.0  50.0  13.4  0.529
3
Study 10  28.7  29.0  15.0  41.0  9.1
Control 10  43.2  39.5  12.0  70.0  18.6  0.052
7
Study 9  62.9  68.0  10.0  148.0  47.9
Control 10  53.8  48.5  11.0  120.0  31.2  0.968
SD, standard deviation.
a Nonparametric Mann--Whitney test, p < 0.05.
Table  8  p-Values  of  the  statistical  tests.
Compared  days  p-Value
Day  one  ×  day  three 0.007
Day  one  ×  day  seven 0.001
Day  three  ×  day  seven 0.480
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ultimate  goal  of  tissue  repair,  but  that  requires  all  steps  toFor  the  control  group,  the  test  results  indicated  the  non-
rejection  of  the  null  hypothesis  (p  =  0.289).  Thus,  in  this
group,  there  was  no  signiﬁcant  difference  between  the  days
of  assessment  in  relation  to  the  cell  count  score.  The  exper-
imental  group  showed  higher  inﬂammatory  reaction  with
increasing  monomorphic  proliferation  (p  =  0.016).
Number  of  vessels
Hematoxylin  eosin  staining
Initially,  on  each  day  of  assessment  (one,  three,  and  seven),
the  null  hypothesis  in  which  the  number  of  vessels  is  the
same  in  both  groups  was  tested  vs.  the  alternative  hypoth-
esis  of  different  numbers  of  vessels  (Table  7).
Then,  within  each  group,  the  null  hypothesis  that  the
scores  were  the  same  on  the  three  days  of  assessment  was
tested  vs.  the  alternative  hypothesis  that  the  scores  were
not  all  the  same.  There  was  a  greater  proliferation  of  ves-
sels  in  the  control  group  (p  =  0.006).  The  experimental  group
showed  no  signiﬁcant  vessel  proliferation  on  the  assessed
days  (p  =  0.119;  Table  8).
o
o
Table  9  Comparison  in  relation  to  angiogenesis.  The  table  shows  m
tests are  also  given.
Day  Group  n  Mean  Median  
1
Study  10  6742  5949  
Control 8  9371  7737  
3
Study 9  5846  4937  
Control 10  9406  8188  
7
Study 9  4347  4419  
Control 8  7575  6799  
SD, standard deviation.
a Nonparametric Mann--Whitney test, p < 0.05.D34  marker
nitially,  on  each  day  of  assessment  (one,  three,  and  seven),
he  null  hypothesis  that  the  CD34  result  would  be  the  same
n  both  groups  was  tested  vs.  the  alternative  hypothesis  of
ifferent  results  (Table  9).  Then,  within  each  group,  the  null
ypothesis  that  the  CD34  result  was  the  same  on  the  three
ays  of  assessment  was  tested  vs.  the  alternative  hypothesis
hat  the  results  were  not  all  the  same.
There  was  greater  proliferation  in  the  control  group  on
ay  seven  (p  =  0.036),  whereas  there  was  no  signiﬁcant  pro-
iferation  of  vessels  in  the  experimental  group.
iscussion
ince  bismuth  subgallateis  commonly  used  in  medical
ractice,  especially  by  otorhinolaryngologists  and  dermato-
ogists,  we  designed  this  study  to  clarify  the  beneﬁts  of  the
alt  in  surgical  procedures.  Currently  it  is  used  commonly
n  tonsillectomies  in  several  services,  mainly  in  southern
razil.  The  authors  certainly  have  observed  its  beneﬁts  in
heir  service;  it  provides  clearer  visualization  of  the  bleed-
ng  points  in  oropharyngeal  lesions,  in  addition  to  providing
ossible  beneﬁcial  effects  on  healing  and  hemostasis.
The  healing  process  involves  several  reactions  occurring
imultaneously;  thus,  it  is  not  possible  to  separate  the  begin-
ing  and  end  of  each  stage.  In  theory,  however,  the  reaction
s  divided  into  steps:  coagulation,  inﬂammation,  prolifer-
tion,  contraction,  and  remodeling.1 This  process  has  theccur  satisfactorily.
Coagulation  starts  a  few  seconds  after  the  creation
f  the  wound.  The  clot  and  the  extracellular  matrix  are
edian,  minimum,  and  maximum  values.  p-Values  of  statistical
Minimum  Maximum  SD  p-Value a
1348  13,106  3626
3341  21,206  5981  0.460
2131  13,493  3735
3814  15,493  3999  0.079
619.8  7590  2281
2437  15,750  3843  0.036
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ormed;  they  contain  chemical  compounds  (growth  factor)
nd  inﬂammatory  mediators  (cytokines)  that  contribute  to
he  re-epithelialization  and  wound  contraction  processes.
The  inﬂammatory  process  is  characterized  by  hemostasis,
ell  migration,  and  provisional  matrix  deposition.  Platelets
re  essential  for  the  formation  of  the  hemostatic  plug
hat  secretes  multiple  mediators,  including  growth  fac-
ors  released  into  the  damaged  area.  Induced  by  thrombin,
hey  also  undergo  platelet  degranulation  and  release  sev-
ral  growth  factors,  such  as  platelet-derived  growth  factor
PDGF),  transforming  growth  factor    (TGF-), epidermal
rowth  factor  (EGF),  the  transforming  growth  factor    (TGF-
),  and  the  vascular  endothelial  growth  factor  (VEGF),  in
ddition  to  adhesive  glycoproteins,  such  as  ﬁbronectin  and
hrombospondin,  which  are  important  constituents  of  the
rovisional  extracellular  matrix.5,6,8
The  macrophage  is  the  most  important  cell  in  the  healing
rocess.  In  addition  to  a  prominent  role  in  phagocytosis  of
ellular  debris,  macrophages  also  secrete  chemotactic  fac-
ors  that  attract  other  inﬂammatory  cells  to  the  wound  site
nd  produce  prostaglandins,  which  act  as  potent  vasodila-
ors  affecting  the  permeability  of  microvessels.  They  also
repare  the  wound  for  the  proliferative  phase.  The  prolif-
ration  in  healing  scar  formation  promotes  wound  closure.
his  phase  consists  of  re-epithelialization,  ﬁbroplasia,  and
ngiogenesis.
It  was  decided  in  this  study  to  focus  on  the  process  of
ngiogenesis,  as  it  is  crucial  for  healing  and  accounts  for  60%
f  the  repair  tissue.5,6 Stashak  et  al.,  cited  by  Souza  et  al.9
eported  that  angiogenesis  shortens  healing  time  by  increas-
ng  the  supply  of  nutrients  and  cell  entry  into  the  affected
rea,  thus  decreasing  wound  retraction  time.  Balbino  et  al.10
eported  the  migration  of  endothelial  cells  through  the  ves-
el  wall  where  they  then  travel  through  the  extracellular
atrix  toward  the  site  of  injury.  Once  in  the  outer  region
f  the  vessel,  they  undergo  a  differentiation  process  and
cquire  the  capacity  to  form  new  capillary  tubules.  Migrat-
ng  endothelial  cells  form  a  capillary  sprout  outside  of  the
essel,  which  joins  the  originating  capillary,  restoring  blood
ow.
The  formation  of  the  new  vessel  begins  with  tissue  injury,
ith  the  activation  of  macrophages  and  the  substances  they
roduce.  The  proteases  (plasmin  and  collagenases)  digest
he  basement  membrane  and  allow  endothelial  cells  stim-
lated  by  angiogenic  cytokines  to  form  the  new  vascular
undle,  which  invades  the  wound.  Angiogenesis  ceases  by
poptosis.11,12
The  speciﬁc  mechanism  responsible  for  contraction  may
e  due  to  movement  of  myoﬁbroblasts  through  the  extracel-
ular  matrix.  The  latter  have  contractile  actin  and  myosin
bers  in  their  cytoplasm  that  originate  from  mesenchy-
al  stem  cells,  circulating  mononuclear  cells  or  ﬁbrocytes
ituated  around  the  adventitia  of  local  blood  vessels,  a  pro-
ess  facilitated  by  TGF-. Fibroblasts  on  the  wound  margins
how  a  change  in  phenotype  to  myoﬁbroblasts,  with  func-
ional  characteristics  similar  to  those  of  smooth  muscle.
hese  cells  are  aligned  around  deposits  of  new  extracellular
atrix,  establishing  cell-to-cell  connections  and  generatingensilestrength.10
Collagen  modeling  is  a  balance  between  the  synthe-
is  and  degradation  of  collagen.  This  process  is  mediated
y  proteolytic  enzymes  (metalloproteinases),  epidermal
c
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ells,  endothelial  cells,  and  ﬁbroblasts.11 During  remodel-
ng,  there  are  several  stages  of  production,  digestion,  and
rientation  of  the  collagen  ﬁbers.  The  ﬁbers  are  digested
y  collagenase,  resynthesized,  rearranged  according  to
he  array  of  adjacent  connective  tissue  ﬁbers,  and  con-
ected  laterally  by  covalent  bonds.  The  amount  of  collagen
ncreases  during  the  ﬁrst  week,  and  by  21  days,  there  is
 balance  between  production  and  degradation.  Scar  resis-
ance  is  given  by  the  amount  of  deposited  collagen  and  the
anner  in  which  the  ﬁbers  are  arranged,  with  resistance
eing  greater  than  it  would  be  expected  only  by  collagen
eposition.  This  process  begins  around  the  third  week  after
he  injury  and  persists  for  months  or  years.10,13
The  objective  for  surgical  recovery  is  for  faster  and
ore  effective  tissue  recovery.  The  present  study  aimed
o  evaluate  bismuth  subgallateon  wound  healing,  hoping  to
mprove  the  response  to  trauma.  Bismuth  subgallate  or  bis-
uth  oxygallate  is  a yellowish  substance,  which  presents  as
n  odorless  powder  that  suffers  discoloration  in  the  pres-
nce  of  sunlight.1 It  is  a  heavy  metal  salt,  little  adsorbed,
nd  has  strong  astringent  power.2
This  compound  has  been  used  to  contain  hemorrhages
n  tonsillectomy,  turbinectomy,  and  partial  hepatectomy.2
ismuth  subgallate,  a  heavy  metal,  relatively  insoluble,  and
oorly  absorbed  from  the  surgical  bed,  is  inexpensive  and
asy  to  use,  and  is  effective  as  a  local  hemostatic  agent.
ts  mechanism  of  action  is  attributed  to  the  activation  of
lotting  factor  12,  in  addition  to  a  presumed  local  astringent
ffect.14
Arroyo  Júnior  et  al.2 also  stated  that  bismuth  subgal-
ate  acts  in  the  activation  of  factor  12,  which  accelerates
he  intrinsic  coagulation  cascade  pathway,  contributing
o  the  hemostatic  characteristic  of  this  compound.  The
uthors  discussed  the  possibility  that  bismuth  subgallate  can
nhibit  ﬁbrinolysis  and,  thereby,  increase  ﬁbrosis.  This  state-
ent  prompted  us  to  design  this  study  to  demonstrate  the
ontribution  of  bismuth  subgallate  to  the  healing  process
nd,  consequently,  to  increased  formation  of  new  vessels.
With  respect  to  the  inﬂammatory  process  as  measured
y  the  number  of  mononuclear  and  polymorphonuclear
ells,  the  study  demonstrated  that  the  experimental  group
ad  reduced  inﬂammatory  process  time,  i.e.,  the  tissue  was
xposed  to  a  faster  inﬂammatory  reaction,  which  did  not
esult  in  the  expected  new  cell  formation.
The  study  demonstrated  that  bismuth  subgallate  pro-
oted  a  signiﬁcant  difference  in  inﬂammatory  pattern,  and
n  the  seventh  day,  the  bismuth  subgallate  promoted  a
eduction  in  the  inﬂammatory  process,  leading  to  a  more
arked  chronic  status  than  in  the  control  group.
Results  of  the  hematoxylin-eosin  staining  revealed  that
he  bismuth  subgallate  did  not  promote  an  increase  in  ves-
els  compared  to  the  control  group.  But  when  comparing
ngiogenesis  of  the  ﬁrst  with  the  seventh  day  in  the  con-
rol  group,  a signiﬁcant  increase  in  the  number  of  vessels
as  observed.  This  association  is  expected  during  the  nor-
al  physiological  healing  process.  When  angiogenesis  was
ssessed  by  the  immunohistochemical  method  with  CD34
arker,  a  greater  proliferation  of  vessels  was  observed  in  the
ontrol  group,  demonstrating  that  the  subgallate  inhibited
eoangiogenesis  in  the  experiment.  The  salt  promoted  a
tatus  of  chronic  inﬂammation,  which  may  explain  the  inhi-
ition  of  angiogenesis  compared  to  the  control  group.
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como agente hemostático. Rev Bras Otorrinolaringol. 2000;66:
194--7.Experimental  study  on  the  effects  of  bismuth  subgallate  on  
Collagen  activity  was  another  factor  evaluated  in  the
present  study.  It  was  afﬁrmed  that  collagen  is  the  most  abun-
dant  connective  tissue  protein  in  the  healing  phase.15 This
protein  primarily  comprises  the  extracellular  matrix  and  is
part  of  the  remodeling  phase  of  healing.
Type  I collagen  is  the  most  common  collagen  type;  it  is
synthesized  by  ﬁbroblasts  and  is  most  prevalent  in  bones
and  tendons.  Type  III  is  most  commonly  found  in  soft  tissues,
such  as  blood  vessels,  dermis,  and  fascia.  The  healthy  dermis
contains  approximately  80%  of  type  I  collagen  and  20%  type
III  collagen.  Granulation  tissue  expresses  30--40%  of  type  III
collagen,  immaturecollagen.15
There  was  no  difference  in  collagen  production,  as  the
control  and  experimental  groups  showed  the  same  efﬁ-
ciency.
Conclusion
A  possible  negative  effect  of  bismuth  subgallate  on  the  heal-
ing  process  in  the  mucosal  wounds  of  the  assessed  animals
was  observed.  The  salt  resulted  in  less  tissue  exposure  to
the  inﬂammatory  process,  leading  to  an  early  chronic  status
with  some  stabilization  in  the  number  of  vessels,  thereby
even  delaying  the  physiological  healing  process  and  impair-
ing  angiogenesis.
The  bismuth  subgallate  stimulus  to  ﬁbroplasia  was  indif-
ferent,  as  it  did  not  interfere  in  collagen  formation,  either
in  its  immature  or  mature  form.
But  when  considering  the  entirety  of  the  healing  pro-
cess,  we  demonstrated  that  the  subgallate  does  not  improve
the  quality  of  healing,  and  the  heavy  metal  also  interferes
by  delaying  the  rate  of  new  vessel  formation  and  optimal
healing  of  the  surgical  wound.
Conﬂicts of interest
The  authors  declare  no  conﬂicts  of  interest.
References1. Mandelbaum SH, Di Santis EP, Mandelbaum MHS. Cicatrizac¸ão:
conceitos atuais e recursos auxiliares/Parte I. An Bras Dermatol.
2003;78:393--410.
1nﬂammatory  process  25
2. Arroyo Júnior PC, Silva RCMA, Santi Neto D, Santana Júnior D,
Ferreira FD, Silva RF. Uso do subgalato de bismuto para hemosta-
sia local em hepatectomisas parciais de ratos. Rev Col Bras Cir.
2004;31:165--71.
3. Paz SHH, Reyes AO, Guzmán CMG. Estudio comparativo de dos
agentes hemostáticos adicionados con epinefrina en la ade-
noamigdalectomía. Rev Esp Méd Quir. 2012;17:3--7.
4. Padilla RM, Valdés CM, Asato JR, Márquez M, Gutiérrez SC,
González YA, et al. Eﬁcacia del subgalato de bismuto, como
agente hemostático tópico, en el sangrado transoperatorio
de la adenoamigdalectomía o amigdalectomía. An Orl Mex.
2012;57:65--8.
5. Arnold F, West DC. Angiogenesis in wound healing. Pharmacol
Ther. 1991;52:407--22.
6. Mendonca RJ, Coutinho-Netto J. Aspectos celulares da
cicatrizac¸ão. An Bras Dermatol. 2009;84:257--62.
7. Fonseca VRCD, Malafaia O, Ribas Filho JM, Nassif PAN, Czeczko
NG, Marcondes CAP, et al. Angiogenesis, ﬁbrinogenesis and
presence of synechiae after exeresis of a swine vocal fold
mucosal microﬂap and use of topical mitomycin-C. Acta Cir
Bras. 2010;25:80--5.
8. Streit M, Velasco P, Riccardi L, Spencer L, Brown LF, Janes L,
et al. Thrombospondin-1 suppresses wound healing and granu-
lation tissue formation in the skin of transgenic mice. EMBO J.
2000;19:3272--82.
9. Souza DW, Machado TSL, Zoopa ALV, Cruz RSF, Gárague AP, Silva
LCLC. Ensaio da aplicac¸ão de creme à base de Triticum vulgare
na cicatrizac¸ão de feridas cutâneas induzidas em eqüinos. Rev
Bras Pl Med. 2006;8:9--13.
0. Balbino CA, Pereira LM, Curi R. Mecanismos envolvidos na
cicatrizac¸ão: uma revisão. Rev Bras Cienc Farm. 2005;41:
27--51.
1. Hanson D, Langemo D, Thompson P, Anderson J, Hunter S.
Understanding wound ﬂuid and the phases of healing. Adv Skin
Wound Care. 2005;18:360--2.
2. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med.
1999;341:738--46.
3. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical
correlation with cellular and molecular events. Dermatol Surg.
2005;31:674--86.
4. Molina FD, Maniglia JV, Magalhães FP, Daﬁco SR, Rezende
RS. A eﬁcácia do subgalato de bismuto em tonsilectomias5. Campos ACL, Borges-Branco A, Groth AK. Cicatrizac¸ão de feri-
das. Arq Bras Cir Dig. 2007;20:51--8.
